Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEOGEN CORPORATION

(NEOG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Neogen : Secures AOAC Approval for Soleris Direct Yeast, Mold Test in Dried Cannabis Flower

06/17/2021 | 12:03pm EDT


ę MT Newswires 2021
All news about NEOGEN CORPORATION
07/30NEOGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
07/28NEOGEN : Launches Reveal« Q+ for Δ9-THC in Hemp
PR
07/28Neogen Launches Reveal« Q+ for ?9-THC in Hemp
CI
07/21NEOGEN : Reports Record Revenues for Fiscal 2021 (Form 8-K)
PU
07/21NEOGEN CORP : Results of Operations and Financial Condition, Financial Statement..
AQ
07/20NEOGEN : Q4 Earnings Flat, Revenue Higher
MT
07/20NEOGEN : Fiscal Q4 Earnings Snapshot
AQ
07/20NEOGEN : Earnings Flash (NEOG) NEOGEN CORPORATION Posts Q4 EPS $0.15
MT
07/20NEOGEN : Earnings Flash (NEOG) NEOGEN CORPORATION Posts Q4 Revenue $127.4M
MT
07/20NEOGEN : Reports Record Revenues for Fiscal 2021
PR
More news
Financials (USD)
Sales 2022 516 M - -
Net income 2022 73,9 M - -
Net cash 2022 180 M - -
P/E ratio 2022 62,4x
Yield 2022 -
Capitalization 4 682 M 4 682 M -
EV / Sales 2022 8,72x
EV / Sales 2023 8,11x
Nbr of Employees 1 841
Free-Float 99,7%
Chart NEOGEN CORPORATION
Duration : Period :
Neogen Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEOGEN CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 43,56 $
Average target price 37,00 $
Spread / Average Target -15,1%
EPS Revisions
Managers and Directors
John E. Adent President, CEO & Director
Steven James Quinlan Chief Financial Officer, Secretary & VP
James C. Borel Chairman
Mark A. Mozola Vice President-Research & Development
Joseph M. Madden Vice President-Scientific Affairs
Sector and Competitors
1st jan.Capi. (M$)
NEOGEN CORPORATION9.86%4 682
ABBOTT LABORATORIES10.49%214 960
MEDTRONIC PLC12.10%176 468
BECTON, DICKINSON AND COMPANY2.21%74 377
ALIGN TECHNOLOGY, INC.30.21%55 063
SARTORIUS STEDIM BIOTECH65.28%52 629